ARCHIVES

FDA’s Oncologic Drugs Advisory Committee recommended approval of three drugs for cancer, voted down one.

This article is from The Cancer Letter archive.

Vol. 31 No. 33 | September 16, 2005

Download PDF Visit The Full Archive

Related Articles

Nature Editorial Criticizes NCI PR Spending

March 15, 2013

Opposition To Lederberg May Have Caused Delay In Panel Appointments; FY 19809 Funds Held Up

October 5, 1979

In Brief: Medical School Deans Biggest Enemy Of Cancer Program, Saunders Says; House Oks Line Item

May 16, 1980

Maguire Backs Cancer Program But Insists On New Emphasis for Prevention

January 26, 1979

NCAB Says President’s Budget Would “Seriously Damage” Cancer Program

February 12, 1999

Breast Cancer Coalition Plans Petition Urging Comprehensive Strategy

May 14, 1993